Switzerland -
German -
Swissmedic (Swiss Agency for Therapeutic Products)
votubia 10 mg tabletten
novartis pharma schweiz ag - everolimusum - tabletten - everolimusum 10 mg, lactosum 287.50 mg, crospovidonum, hypromellosum, lactosum monohydricum 9.8 mg, magnesii stearas, e 321 pro compresso. - tuberöse sklerose - synthetika
Switzerland -
German -
Swissmedic (Swiss Agency for Therapeutic Products)
votubia 2 mg dispergierbare tabletten
novartis pharma schweiz ag - everolimusum - dispergierbare tabletten - everolimusum 2 mg, lactosum monohydricum 1.96 mg, hypromellosum, mannitolum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, e 321 pro compresso. - tuberöse sklerose - synthetika
Switzerland -
German -
Swissmedic (Swiss Agency for Therapeutic Products)
votubia 3 mg dispergierbare tabletten
novartis pharma schweiz ag - everolimusum - dispergierbare tabletten - everolimusum 3 mg, lactosum monohydricum 2.94 mg, hypromellosum, mannitolum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, e 321 pro compresso. - tuberöse sklerose - synthetika
Switzerland -
German -
Swissmedic (Swiss Agency for Therapeutic Products)
votubia 5 mg dispergierbare tabletten
novartis pharma schweiz ag - everolimusum - dispergierbare tabletten - everolimusum 5 mg, lactosum monohydricum 4.90 mg, hypromellosum, mannitolum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, e 321 pro compresso. - tuberöse sklerose - synthetika
Netherlands -
Dutch -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
everolimus dr. reddy's 10 mg, tabletten
dr. reddy's laboratories (uk) ltd. - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b) - everolimus
Netherlands -
Dutch -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
everolimus dr. reddy's 2,5 mg, tabletten
dr. reddy's laboratories (uk) ltd. - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b) - everolimus
Netherlands -
Dutch -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
everolimus dr. reddy's 5 mg, tabletten
dr. reddy's laboratories (uk) ltd. - everolimus - tablet - butylhydroxytolueen (e 321) ; crospovidon (e 1202) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; magnesiumstearaat (e 470b) - everolimus
Ireland -
English -
HPRA (Health Products Regulatory Authority)
everolimus teva 2.5 mg tablets
teva b.v. - everolimus - tablet - 2.5 milligram(s) - protein kinase inhibitors; everolimus
Russia -
Russian -
Государственный реестр лекарственных средств
Николимус
Акционерное общество "Фармацевтический импорт, экспорт"( АО "Фармимэкс") (Россия) - Эверолимус - таблетки - 10 мг; 2.5 мг - противоопухолевое средство - протеинкиназы ингибитор - Эверолимус
Uzbekistan -
Russian -
Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi (Министерство здравоохранения Республики Узбекистан)
ЭВЕРОЛИМУС-ВИСТА(everolimus-vista)
mistral capital management limited, Англия произведено: synton hispania s. l. - everolimus - Таблетки 10 мг n30 (6х5) (блистеры) - Иммунодепрессивное средство